Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma

Cancer Science

Volumn 107, Issue 2, 2016, Pages 149-154

  Konishi, Hirotaka ^a   Ichikawa, Daisuke ^a   Yamamoto, Yusuke ^a   Arita, Tomohiro ^a   Shoda, Katsutoshi ^a   Hiramoto, Hidekazu ^a   Hamada, Junichi ^a   Itoh, Hiroshi ^a   Fujita, Yuji ^a   Komatsu, Shuhei ^a   Shiozaki, Atsushi ^a   Ikoma, Hisashi ^a   Ochiai, Toshiya ^b   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Carcinogenesis; Hepatocellular carcinoma; Liver damage; Long non coding RNA; Metastasis associated lung adenocarcinoma transcript 1

Indexed keywords

ALPHA FETOPROTEIN; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VITAMIN K GROUP; LONG UNTRANSLATED RNA; MALAT1 LONG NON-CODING RNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; BLOOD; LIVER DISEASE; LIVER TUMOR; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84958909235     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12854     Document Type: Article

References (37)

1. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-16.
2. Wu CC, Cheng SB, Ho WM, Chen JT, Liu TJ, P'eng FK. Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg 2005; 92: 348-55.
3. Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY, Chen YF. Long-term outcome of resection of large hepatocellular carcinoma. Br J Surg 2006; 93: 600-6.
4. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232: 10-24.
5. Costa FF. Non-coding RNAs: new players in eukaryotic biology. Gene 2005; 357: 83-94.
6. Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-38.
7. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309: 1577-81.
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
9. Morimura R, Komatsu S, Ichikawa D et al. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer 2011; 105: 1733-40.
10. Konishi H, Ichikawa D, Komatsu S et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer 2012; 106: 740-47.
11. Guttman M, Amit I, Garber M et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009; 458: 223-27.
12. Gupta RA, Shah N, Wang KC et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-76.
13. Panzitt K, Tschernatsch MM, Guelly C et al. Characterization of HULC, a novel gene with striking upregulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007; 132: 330-42.
14. Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007; 26: 851-58.
15. Ji P, Diederichs S, Wang W et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early stage non-small cell lung cancer. Oncogene 2003; 22: 8031-41.
16. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 7th edn. Hoboken: Wiley-Blackwell, 2010; 30-8.
17. Arita T, Ichikawa D, Konishi H et al. Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res 2013; 33: 3185-93.
18. Polymenidou M, Lagier-Tourenne C, Hutt KR et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 2011; 14: 459-68.
19. Macias S, Plass M, Stajuda A, Michlewski G, Eyras E, Cáceres JF. DGCR8 HITS-CLIP reveals novel functions for the Microprocessor. Nat Struct Mol Biol 2012; 19: 760-66.
20. Tripathi V, Ellis JD, Shen Z et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 2010; 39: 925-38.
21. Yang L, Lin C, Liu W et al. ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 2011; 147: 773-88.
22. Gutschner T, Hammerle M, Diederichs S. MALAT1 - a paradigm for long noncoding RNA function in cancer. J Mol Med 2013; 91: 791-801.
23. Schmidt LH, Spieker T, Koschmieder S et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol 2011; 6: 1984-92.
24. Xu D, Yang F, Yuan JH et al. Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/beta-Catenin signaling. Hepatology 2013; 58: 739-51.
25. Yamamoto Y, Nishikawa Y, Tokairin T, Omori Y, Enomoto K. Increased expression of H19 non-coding mRNA follows hepatocyte proliferation in the rat and mouse. J Hepatol 2004; 40: 808-14.
26. Luo JH, Ren B, Keryanov S et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006; 44: 1012-24.
27. Puthanveetil P, Chen S, Feng B, Gautam A, Chakrabarti S. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med 2015; 19: 1418-25.
28. Liu Y, Pan S, Liu L et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS ONE 2012; 7: e35145.
29. Chen TM, Huang PT, Tsai MH et al. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy. J Gastroenterol Hepatol 2007; 22: 669-75.
30. Tai WC, Hu TH, Wang JH et al. Clinical implications of alpha-fetoprotein in chronic hepatitis C. J Formos Med Assoc 2009; 108: 210-18.
31. Silver HK, Gold P, Shuster J, Javitt NB, Freedman SO, Finlayson ND. Alpha(1)-fetoprotein in chronic liver disease. N Engl J Med 1974; 291: 506-8.
32. Yang SS, Cheng KS, Lai YC et al. Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B. J Gastroenterol 2002; 37: 626-32.
33. Horn KD, Wax P, Schneider SM et al. Biomarkers of liver regeneration allow early prediction of hepatic recovery after acute necrosis. Am J Clin Pathol 1999; 112: 351-57.
34. Cui R, He J, Zhang F et al. Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein. Br J Cancer 2003; 88: 1878-82.
35. Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002; 36: 410-17.
36. Tsai SL, Huang GT, Yang PM, Sheu JC, Sung JL, Chen DS. Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma. Hepatology 1990; 11: 481-88.
37. Ishii M, Gama H, Chida N et al. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Am J Gastroenterol 2000; 95: 1036-40.